Incannex Healthcare (IXHL) Payables (2020 - 2026)
Incannex Healthcare (IXHL) posted quarterly Payables of $1.6 million for Q1 2026, down 34.24% year-on-year from $2.4 million in Q1 2025, and up 30.67% on a QoQ basis from $1.2 million in Q4 2025.
Incannex Healthcare (IXHL) Payables (2020 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Payables for 7 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.
- Quarterly Payables fell 34.24% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 34.24% YoY) and the FY2025 annual result came in at $6.1 million, up 1052.56% from the prior year.
- Payables grew to $1.6 million in Q1 2026 per IXHL's latest filing, from $1.2 million in the prior quarter.
- Over the last five years, Payables for IXHL reached as high as $6.1 million in Q2 2025 and fell as low as $527000.0 in Q2 2024.
- A 5-year average of $1.9 million and a median of $1.6 million in 2026 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables slumped 69.85% — and 2025, when it soared 1052.56%.
- Year by year, Payables stood at $1.1 million in 2022, then soared by 82.58% to $2.0 million in 2023, then increased by 12.76% to $2.2 million in 2024, then plunged by 44.3% to $1.2 million in 2025, then surged by 30.67% to $1.6 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $1.6 million, $1.2 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 6.07 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 527,000.00 |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Jun 30, 2021 | 755,049.00 |
| Jun 30, 2020 | 955,006.00 |